References
Duwe G, Boehm K, Haack M, Sparwasser P, Brandt MP, Mager R et al (2023) Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected. World J Urol 41(5):1293–1299
Huber PM, Afzal N, Arya M, Boxler S, Dudderidge T, Emberton M et al (2020) Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound. J Urol 203(4):734–742
Abreu AL, Peretsman S, Iwata A, Shakir A, Iwata T, Brooks J et al (2020) High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series. J Urol 204(4):741–747
Farolfi A, Calderoni L, Mattana F, Mei R, Telo S, Fanti S et al (2021) Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer. J Nucl Med Off Publ Soc Nucl Med 62(5):596–604
Kotamarti S, Gupta RT, Wang B, Séguier D, Michael Z, Zhang D, et al. Reconciling Discordance Between Prostate Biopsy Histology and Magnetic Resonance Imaging Suspicion – Implementation of a Quality Improvement Protocol of Imaging Re-review and Reverse-fusion Target Analysis. Eur Urol Oncol [Internet]. 2022 Jul 22 [cited 23 Sep 2022];0(0). Available from: https://euoncology.europeanurology.com/article/S2588-9311(22)00109-2/fulltext
Author information
Authors and Affiliations
Contributions
DS, JO: manuscript writing. AV: manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Séguier, D., Villers, A. & Olivier, J. Standardized reports of focal-HIFU results is paramount: a closer look at the Duwe et al.’s cohort on focal HIFU for localized prostate cancer. World J Urol 41, 2873–2874 (2023). https://doi.org/10.1007/s00345-023-04567-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-023-04567-w